Q32 Bio (QTTB) SIGNAL-AD trial did not achieve its primary endpoint, SIGNAL-AA demonstrated encouraging clinical activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. QCOM
5. IONS
6. AZN
7. NVS
8. ROIV
9. ORCL
10. AAPL

Go back to Q32 Bio (QTTB) SIGNAL-AD trial did not achieve its primary endpoint, SIGNAL-AA demonstrated encouraging clinical activity
(NASDAQ: QTTB) Delayed: 11.69 -0.3 (2.5%)
Previous Close $11.99    52 Week High $ 
Open $12.00    52 Week Low $ 
Day High $12.00    P/E N/A 
Day Low $11.57    EPS $ 
Volume 592,921